AI RESEARCH
Assessing Pancreatic Ductal Adenocarcinoma Vascular Invasion: the PDACVI Benchmark
arXiv CS.CV
•
ArXi:2604.27582v1 Announce Type: new Surgical resection remains the only potentially curative treatment for pancreatic ductal adenocarcinoma (PDAC), and eligibility depends on accurate assessment of vascular invasion (VI), i.e., tumor extension into adjacent critical vessels. Despite its importance for preoperative staging and surgical planning, computational VI assessment remains underexplored. Two major challenges are the lack of public datasets and the diagnostic ambiguity at the tumor-vessel interface, which leads to substantial inter-rater variability even among expert radiologists.